EF
ZBH icon

Empowered Funds’s Zimmer Biomet ZBH Stock Holding History

Empowered Funds’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$782K Buy
9,079
+1,356
+18% +$119K ﹤0.01% 1528
2026
Q1 		$698K Sell
7,723
-252
-3% -$23.1K ﹤0.01% 1535
2025
Q4 		$717K Sell
7,975
-10,553
-57% -$1M 0.01% 691
2025
Q3 		$1.83M Buy
18,528
+819
+5% +$81.2K 0.02% 963
2025
Q2 		$1.62M Buy
17,709
+12,937
+271% +$1.25M 0.02% 915
2025
Q1 		$540K Hold
4,772
– – 0.01% 1189
2024
Q4 		$504K Buy
4,772
+637
+15% +$68.3K 0.01% 1175
2024
Q3 		$446K Buy
4,135
+265
+7% +$28.9K 0.01% 1122
2024
Q2 		$420K Buy
3,870
+113
+3% +$13.3K 0.01% 1104
2024
Q1 		$496K Buy
3,757
+1,262
+51% +$158K 0.01% 1079
2023
Q4 		$304K Buy
2,495
+664
+36% +$74.1K 0.01% 1110
2023
Q3 		$205K Buy
1,831
+340
+23% +$43.2K 0.01% 1143
2023
Q2 		$217K Buy
+1,491
New +$203K 0.01% 1056

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Empowered Funds's ZBH Position: Q2 2026 in Review

Empowered Funds increased its Zimmer Biomet (ZBH) stake by 18% in Q2 2026, buying an estimated $119K and bringing the position to 9,079 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Empowered Funds first reported a position in ZBH in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.83M in Q3 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Empowered Funds held 9,079 shares of Zimmer Biomet worth $782K as of Q2 2026.
  • Empowered Funds bought 1,356 Zimmer Biomet shares in Q2 2026, an estimated $119K.
  • Zimmer Biomet made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1528 holding.
  • Empowered Funds first reported a position in Zimmer Biomet in Q2 2023 and has held it in 13 quarters since.
  • Empowered Funds's Zimmer Biomet position peaked at $1.83M in Q3 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.